Applied DNA Sciences Inc (APDN) financial statements (2021 and earlier)

Company profile

Business Address 50 HEALTH SCIENCES DRIVE
STONY BROOK, NY 11790
State of Incorp. DE
Fiscal Year End September 30
SIC 738 - Miscellaneous Business Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4812347
Cash and cash equivalents4812347
Receivables1011364
Inventory, net of allowances, customer advances and progress billings100000 
Inventory100000 
Prepaid expense      0
Deferred costs     0 
Other undisclosed current assets111100 
Total current assets:792461112
Noncurrent Assets
Property, plant and equipment2100111
Long-term investments and receivables     22
Accounts and financing receivable, after allowance for credit loss     22
Intangible assets, net (including goodwill)1111122
Goodwill0000000
Intangible assets, net (excluding goodwill)1111122
Deposits noncurrent assets000000 
Deferred costs  0    
Other undisclosed noncurrent assets     00
Total noncurrent assets:3212244
TOTAL ASSETS:10114681616
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2221122
Accounts payable2111021
Accrued liabilities0000000
Employee-related liabilities0100011
Taxes payable  0    
Deferred revenue011
Debt12     
Deferred revenue and credits020
Other undisclosed current liabilities   2   
Total current liabilities:3423143
Noncurrent Liabilities
Long-term debt and lease obligation0112  0
Long-term debt, excluding current maturities0112  0
Liabilities, other than long-term debt1110 1 
Deferred revenue and credits 1 
Accounts payable and accrued liabilities1110   
Other undisclosed noncurrent liabilities  0  0 
Total noncurrent liabilities:1122 10
Total liabilities:4645153
Stockholders' equity
Stockholders' equity attributable to parent, including:66(1)171013
Common stock000000 
Additional paid in capital280276256249244234224
Accumulated deficit(275)(270)(257)(248)(237)(224)(212)
Other undisclosed stockholders' equity attributable to parent      0
Stockholders' equity attributable to noncontrolling interest(0)(0)(0)    
Total stockholders' equity:66(1)171013
TOTAL LIABILITIES AND EQUITY:10114681616

Income statement (P&L) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Revenues3254549
Revenue, net549
Cost of revenue(1)(1)(1)(1)(1)(1) 
Cost of goods and services sold  (1)    
Gross profit:2153439
Operating expenses(15)(14)(14)(14)(16)(16)(17)
Operating loss:(13)(13)(9)(12)(13)(12)(8)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(0)(0)(0)(0)0(0)
Interest and debt expense(2)(0)(1)(0)  (0)
Loss from continuing operations before equity method investments, income taxes:(15)(13)(10)(12)(13)(12)(8)
Other undisclosed income (loss) from continuing operations before income taxes(0)(0)2(0)00(4)
Loss from continuing operations before income taxes:(15)(13)(9)(12)(13)(12)(12)
Income tax expense (benefit) 4(0)(4)55(10)
Other undisclosed income from continuing operations4      
Loss before gain (loss) on sale of properties:(12)(10)(9)(15)(8)(7)(22)
Other undisclosed net loss(6)(4)     
Net loss:(18)(13)(9)(15)(8)(7)(22)
Net income (loss) attributable to noncontrolling interest(0)00    
Other undisclosed net income (loss) attributable to parent3  4(5)(5)10
Net loss attributable to parent:(15)(13)(9)(12)(13)(12)(12)
Other undisclosed net loss available to common stockholders, basic (0)(0)    
Net loss available to common stockholders, diluted:(15)(13)(9)(12)(13)(12)(12)

Comprehensive Income ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Net loss:(18)(13)(9)(15)(8)(7)(22)
Comprehensive loss:(18)(13)(9)(15)(8)(7)(22)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(0)00    
Comprehensive loss, net of tax, attributable to parent:(18)(13)(9)(15)(8)(7)(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: